These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23264438)

  • 1. Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
    Seo S; Englund JA; Nguyen JT; Pukrittayakamee S; Lindegardh N; Tarning J; Tambyah PA; Renaud C; Went GT; de Jong MD; Boeckh MJ
    Antivir Ther; 2013; 18(3):377-86. PubMed ID: 23264438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation.
    Kim WY; Young Suh G; Huh JW; Kim SH; Kim MJ; Kim YS; Kim HR; Ryu YJ; Han MS; Ko YG; Chon GR; Lee KH; Choi SH; Hong SB;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5703-9. PubMed ID: 21968371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus.
    Hoopes JD; Driebe EM; Kelley E; Engelthaler DM; Keim PS; Perelson AS; Rong L; Went GT; Nguyen JT
    PLoS One; 2011; 6(12):e29778. PubMed ID: 22220216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.
    Nguyen JT; Smee DF; Barnard DL; Julander JG; Gross M; de Jong MD; Went GT
    PLoS One; 2012; 7(1):e31006. PubMed ID: 22292088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.
    Beigel JH; Bao Y; Beeler J; Manosuthi W; Slandzicki A; Dar SM; Panuto J; Beasley RL; Perez-Patrigeon S; Suwanpimolkul G; Losso MH; McClure N; Bozzolo DR; Myers C; Holley HP; Hoopes J; Lane HC; Hughes MD; Davey RT;
    Lancet Infect Dis; 2017 Dec; 17(12):1255-1265. PubMed ID: 28958678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.
    Nguyen JT; Hoopes JD; Le MH; Smee DF; Patick AK; Faix DJ; Blair PJ; de Jong MD; Prichard MN; Went GT
    PLoS One; 2010 Feb; 5(2):e9332. PubMed ID: 20179772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH; Bailey KW; Morrey JD
    Antimicrob Agents Chemother; 2009 May; 53(5):2120-8. PubMed ID: 19273672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous detection of oseltamivir- and amantadine-resistant influenza by oligonucleotide microarray visualization.
    Zhang Y; Liu Q; Wang D; Chen S; Wang S
    PLoS One; 2013; 8(2):e57154. PubMed ID: 23451169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological clearance rate of high-dose oseltamivir or triple-combination antiviral therapy in complicated 2009 pandemic influenza A (H1N1) infection.
    Kang SJ; Park KH; Kee SJ; Shin JH; Jung SI; Kwon YS; Jang HC
    Jpn J Infect Dis; 2013; 66(5):425-7. PubMed ID: 24047743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivirals for the chemoprophylaxis and treatment of influenza.
    Van Voris LP; Newell PM
    Semin Respir Infect; 1992 Mar; 7(1):61-70. PubMed ID: 1609169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A change in the effectiveness of amantadine for the treatment of influenza over the 2003-2004, 2004-2005, and 2005-2006 influenza seasons in Japan.
    Kawai N; Ikematsu H; Iwaki N; Kawamura K; Kawashima T; Kashiwagi S
    J Infect Chemother; 2007 Oct; 13(5):314-9. PubMed ID: 17982720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged shedding of amantadine- and oseltamivir-resistant influenza A(H3N2) virus with dual mutations in an immunocompromised infant.
    Ruiz-Carrascoso G; Casas I; Pozo F; González-Vincent M; Pérez-Breña P
    Antivir Ther; 2010; 15(7):1059-63. PubMed ID: 21041923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
    Finberg RW; Lanno R; Anderson D; Fleischhackl R; van Duijnhoven W; Kauffman RS; Kosoglou T; Vingerhoets J; Leopold L
    J Infect Dis; 2019 Mar; 219(7):1026-1034. PubMed ID: 30428049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
    Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
    Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy.
    Piralla A; Gozalo-Margüello M; Fiorina L; Rovida F; Muzzi A; Colombo AA; Alessandrino PE; Baldanti F
    J Clin Virol; 2013 Sep; 58(1):132-7. PubMed ID: 23810646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
    Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
    Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antiviral agents for the management of severe influenza.
    Smith JR; Ariano RE; Toovey S
    Crit Care Med; 2010 Apr; 38(4 Suppl):e43-51. PubMed ID: 19935416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.
    Couturier BA; Bender JM; Schwarz MA; Pavia AT; Hanson KE; She RC
    Influenza Other Respir Viruses; 2010 Jul; 4(4):199-204. PubMed ID: 20836794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.